Catalog Products » SARS-CoV-2 Spike protein RBD, Omicron Variant, His Tag
SARS-CoV-2 Spike Protein RBD, Omicron Variant, His Tag

The purity is greater than 95% as determined by reducing SDS-PAGE.

SARS-CoV-2 Spike Protein RBD, Omicron Variant, His Tag

Immobilized ACE-2 Fc Chimera, Human at 2 μg/ml can bind SARS-CoV-2 Spike protein RBD, Omicron Variant, His Tag (Cat.No. Z03728) with a serial dilution.

THE™ His Tag Antibody [HRP], mAb, Mouse (Cat.No. A00612) is used as a secondary antibody (0.2 μg/ml).

SARS-CoV-2 Spike protein RBD, Omicron Variant, His Tag

SARS-CoV-2 (Severe Acute Respiratory Syndrome Coronavirus 2) also known as 2019-nCoV (2019 Novel Coronavirus) is a virus that causes illnesses ranging from the common cold to severe diseases. Recently, the new B.1.1.529 variant was confirmed in South Africa and preliminary evidence suggests an increased risk of reinfection with this variant. The B.1.1.529 variant was first reported to WHO on 24 November 2021 and WHO has designated this variant as a VOC (Variant of Concern), named Omicron. There are more than 30 mutations in the spike protein.
Z03728
$380.00

Ask us a question
Product Introduction
Species SARS-CoV-2
Protein Construction

Expressed with the mutations of G339D, S371L, S373P, S375F, K417N, N440K, G446S, S477N, T478K, E484A, Q493R, G496S, Q498R, N501Y, Y505H.

Spike RBD (Arg319-Phe541)
Accession # P0DTC2
Poly-His
N-term C-term
Purity ≥ 95% as analyzed by SDS-PAGE
Endotoxin Level ≤ 1 EU/μg of protein by LAL method.
Biological Activity SARS-CoV-2 Spike protein RBD, Omicron Variant, His Tag can bind with human ACE2 in functional ELISA assay.
Expression System Human Cells
Theoretical Molecular Weight 26.2 kDa
Apparent Molecular Weight 32-40 kDa, on SDS-PAGE under reducing conditions.
Formulation Supplied as a 0.2 μm filtered solution of PBS, pH 7.4.
Concentration Please refer to the COA for the specific lot.
Storage & Stability Upon receiving, this product remains stable for up to 6 months at -20 °C or below. Avoid repeated freeze-thaw cycles.

Examples
  • SARS-CoV-2 Spike Protein RBD, Omicron Variant, His Tag
  • SARS-CoV-2 Spike Protein RBD, Omicron Variant, His Tag

    The purity is greater than 95% as determined by reducing SDS-PAGE.

  • SARS-CoV-2 Spike Protein RBD, Omicron Variant, His Tag
  • SARS-CoV-2 Spike Protein RBD, Omicron Variant, His Tag

    Immobilized ACE-2 Fc Chimera, Human at 2 μg/ml can bind SARS-CoV-2 Spike protein RBD, Omicron Variant, His Tag (Cat.No. Z03728) with a serial dilution.

    THE™ His Tag Antibody [HRP], mAb, Mouse (Cat.No. A00612) is used as a secondary antibody (0.2 μg/ml).


Background
Target Background SARS-CoV-2 (Severe Acute Respiratory Syndrome Coronavirus 2) also known as 2019-nCoV (2019 Novel Coronavirus) is a virus that causes illnesses ranging from the common cold to severe diseases. Recently, the new B.1.1.529 variant was confirmed in South Africa and preliminary evidence suggests an increased risk of reinfection with this variant. The B.1.1.529 variant was first reported to WHO on 24 November 2021 and WHO has designated this variant as a VOC (Variant of Concern), named Omicron. There are more than 30 mutations in the spike protein.
Synonyms B.1.1.529; Omicron variant
References 1. Classification of Omicron (B.1.1.529): SARS-CoV-2 Variant of Concern.
2. Omicron: What Is Known — and Still Unknown.  

For laboratory research use only. Direct human use, including taking orally and injection and clinical use are forbidden.


Do you like the current new website?

Hate

Dislike

Neutral

Like

Love

*